Is it time to recommend screening for colorectal cancer?

Lancet

Volumn 348, Issue 9040, 1996, Pages 1463-1464

  Lieberman, D ^a   Sleisenger, M H ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER MORTALITY; CANCER SCREENING; COLON POLYPOSIS; COLONOSCOPY; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; OCCULT BLOOD; PATIENT COMPLIANCE; PRIORITY JOURNAL; SHORT SURVEY; SIGMOIDOSCOPY;

EID: 0029798923     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)65886-2     Document Type: Note

References (6)

1. JS Mandel JH Bond TR Church Reducing mortality from colorectal cancer by screening for fecal occult blood N Engl J Med 328 1993 1365 1371
2. JE Allison IS Tekawa LJ Ransom AL Adrain A comparion of fecal occult blood tests for colorectal cancer screening N Engl J Med 334 1996 155 159
3. SJ Winawer AG Zauber MN Ho Prevention of colorectal cancer by colonoscopic polypectomy N Engl J Med 329 1993 1977 1981
4. JV Selby GD Friedman CP Quesenberry A case-control study of screening sigmoidoscopy and mortality form colorectal cancer N Engl J Med 326 1992 653 657
5. Lieberman DA. Prospective evaluation of risk factors of large (>1cm) colonic adenomas in asymptomatic subjects. VA Cooperative Studies Program Update, December 1995-May, 1996.
6. JL Wagner S Tunis M Brown Cost-effectiveness of colorectal cancer screening in average-risk adults Young GP Rozen P Levin B Prevention and early detection of colorectal cancer 1996 WB Saunders London 321 356